EDITORIAL SECTION

healthcare-management

The Problem with Solutions in Healthcare

Modern healthcare grapples with complex challenges, from workforce shortages and fragmented care to financial pressures...

Medical Sciences

Artificial Intelligence in Cardiovascular Disease

Cardiovascular diseases (CVDs) remain the leading cause of global mortality. Artificial intelligence (AI) has emerged as a transformative tool...

Surgical Speciality

Leveraging AI for Early Detection and Prevention of SSIs

Surgical Site Infections (SSIs) are among the most common healthcare-associated infections, posing substantial challenges...

Diagnostics

Intelligent Automation and AI Point of Care Testing

Over the past two decades, advances in technology have revolutionized healthcare delivery worldwide...

Technology-Equipment

Smart Medical Devices

After ten years in bioengineering, I still find myself amazed at how far we've come. And yes, sometimes that amazement comes...

Facilities & Operations

Integration of AI into Healthcare Facilities

Artificial Intelligence (AI) is defined as the intelligence of machines, as opposed to the intelligence of humans or other living species.

Information Technology

Digital Health Reinvented

The modern healthcare landscape is being reshaped by the integration of Artificial Intelligence (AI) and digital health tools...

EXPERT Talk

Healthcare Transformation using Artificial Intelligence

Explains recent Artificial Intelligence breakthroughs, critically evaluates how AI can be selectively and successfully deployed to alleviate current c...

KNOWLEDGE BANK

Articles

Prevention of Intraoperative Catastrophic Events during Minimally Invasive Lung Cancer Surgery

Lung cancer is the leading cause of cancer deaths in males and females. With the increase of lung cancer screening, early detection of lung cancer has been increasing. The use of minimally invasive surgery for lung cancer, including video-assisted and robotic-assisted surgery, has been increasing with growing evidence of better postoperative pain control

Techno Trends

Ceribell Launches First FDA-Cleared AI-Powered Delirium Monitoring System

Ceribell, Inc. has commercially launched its artificial intelligence (AI)-powered delirium monitoring solution on its point-of-care brain monitoring platform.

Projects

Sarasota Memorial Begins US$82.5 Million Rehabilitation Pavilion Construction in Venice

Sarasota Memorial Health Care System has broken ground on an US$82.5 million Rehabilitation Pavilion at its Venice hospital campus in Florida. The four-storey development will expand access to inpatient and outpatient rehabilitation services for communities in south Sarasota County.

Research Insights

Characterizing acute ischemia via ECG: A study of severity, extent, and spatial variability in myocardial infarction and non-infarction groups

Ischemic heart disease remains the leading cause of mortality worldwide. Its diagnosis largely relies on detecting dynamic changes in the ST segment of the electrocardiogram (ECG). However, alterations in other ECG waves and intervals have also been reported

White Papers

Preventing a Hospital Failure: Key Leadership Pitfalls to Avoid

Hospitals in the United States are facing an unprecedented era of financial distress, stemming from a mix of complex, external challenges. These include labor shortages, declining reimbursement rates

TOP ARTICLES

1

OBBBA Medicaid Cuts and Rural Hospitals: Financial Risks and Preparedness

Kate Williamson

OBBBA Medicaid cuts will reach rural hospitals in stages, starting with eligibility changes in 2027 and financing limits in 2028. With thin margins and heavy Medicaid reliance, many face real closure...

2

Hospital Financial Preparedness for OBBBA Medicaid Cuts: Strategies and Checklist

Sarah Richards

OBBBA Medicaid changes will reshape hospital revenue through work requirements, tighter provider taxes, and capped state-directed payments. This article explains what is changing and when, then gives...

3

How OBBBA Medicaid Cuts Will Hit Hospital Finances and Margins

Sarah Richards

The OBBBA Medicaid cuts hit hospitals twice: coverage losses from work requirements raise uncompensated care, while caps on provider taxes and state-directed payments shrink supplemental revenue. Safe...

press releasesRead more...

Fziomed Announces FDA 510(k) Clearance for Dynavisc® Tendon Protector in the United States

Fziomed Announces FDA 510(k) Clearance for Dynavisc® Tendon Protector in the United States

Fziomed, Inc. ("Fziomed" or the "Company"), a global leader in postsurgical adhesion prevention biomaterials and surgical innovation, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration

GE HealthCare’s Critical Care Suite 3.0 brings first on-device AI for feeding tube detection to X-ray imaging in adult and pediatric care

GE HealthCare’s Critical Care Suite 3.0 brings first on-device AI for feeding tube detection to X-ray imaging in adult and pediatric care

GE HealthCare today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Critical Care Suite 3.0, an AI-enabled software designed to automatically detect feeding tubes on X-ray images

Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system

Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in general surgery procedures.

C2N Diagnostics’ FDA-Cleared PrecivityAD2®: Now Available to Health Care Professionals to Improve Diagnosis of Alzheimer’s Disease in Symptomatic Patients

C2N Diagnostics’ FDA-Cleared PrecivityAD2®: Now Available to Health Care Professionals to Improve Diagnosis of Alzheimer’s Disease in Symptomatic Patients

C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announces that health care professionals can now order the FDA-cleared version of the PrecivityAD2® blood test

EventsRead more...

20 - 21

Nov 2026

InnoHEALTH 2026

Jamia Millia Islamia, New Delhi

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munich

25 - 26

Nov 2026

26 - 27

Nov 2026

26 - 27

Nov 2026

PHC 2026

Barcelona, Spain

03 - 06

Dec 2026

Healthcare+ Expo Taiwan 2026

Taipei, TaiNEX 1, Taiwan

04 - 06

Dec 2026

07 - 08

Dec 2026

The GIANT Health Event 2026

London, England, UK

LATEST NEWSRead more...

InspireMD Completes First US Commercial TCAR Procedures Using FDA-Approved CGuard Prime Stent System

InspireMD has announced the successful completion of the first commercial transcarotid artery revascularisation (TCAR) procedures in the US using its CGuard® Prime TransCarotid Stent System. The procedures follow the US Food and Drug Administration (FDA) premarket approval of the device on 9 Novembe...

CareMore Health and L.A. Care Expand Medicare Access Across Los Angeles County

CareMore Health, a Mosaic Health company providing integrated medical care through a network of healthcare providers in California, has established a new partnership with L.A. Care Health Plan, the largest publicly operated health plan in the US. The arrangement gives L.A. Care Medicare Plus members...

Philips Launches Skylight Device Manager to Turn Ultrasound Data into Operational Insights

Royal Philips has introduced Philips Skylight Device Manager, a cloud-based application designed to help healthcare organisations improve the management and utilisation of ultrasound equipment. The platform brings data from connected

Perfuze Secures FDA Clearance for NeuroSheath 8F Long Sheath, Completing Its Stroke Thrombectomy System

Neurovascular medical device company Perfuze has received 510(k) clearance from the US Food and Drug Administration (FDA) for NeuroSheath, an 8 French (8F) long sheath developed for neurovascular access.

Radical Catheter Technologies Receives FDA Clearance for Reperfusion Catheters to Treat Acute Ischaemic Stroke

Radical Catheter Technologies, a portfolio company of NeuroTechnology Investors (NTI), has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Radical 076 and 064 Reperfusion Catheters. The clearance expands